Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gilead Sciences
Pharma
ESMO: Datroway data edge out Trodelvy in first TROP2 face-off
While control arm crossover may explain the lack of an early survival showing for Trodelvy, it cannot explain another weak point in the drug's data.
Angus Liuu
Oct 19, 2025 2:30am
GSK touts study showing tolerability edge for its long-acting PrEP
Oct 15, 2025 8:45am
Gilead inks Biktarvy settlements with 3 generic drug makers
Oct 7, 2025 7:40am
Dr. Reddy's, Hetero secure support to produce generic Yeztugo
Sep 24, 2025 11:29am
CDC 'strongly recommends' Gilead's HIV PrEP Yeztugo
Sep 19, 2025 11:22am
Gilead claims victory in whistleblower kickback lawsuit
Sep 12, 2025 11:59am
